BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 29915309)

  • 1. CXCR1/Akt signaling activation induced by mesenchymal stem cell-derived IL-8 promotes osteosarcoma cell anoikis resistance and pulmonary metastasis.
    Du L; Han XG; Tu B; Wang MQ; Qiao H; Zhang SH; Fan QM; Tang TT
    Cell Death Dis; 2018 Jun; 9(7):714. PubMed ID: 29915309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCR1 knockdown improves the sensitivity of osteosarcoma to cisplatin.
    Han XG; Du L; Qiao H; Tu B; Wang YG; Qin A; Dai KR; Fan QM; Tang TT
    Cancer Lett; 2015 Dec; 369(2):405-15. PubMed ID: 26391645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.
    Tu B; Du L; Fan QM; Tang Z; Tang TT
    Cancer Lett; 2012 Dec; 325(1):80-8. PubMed ID: 22743617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCR4-mediated osteosarcoma growth and pulmonary metastasis is promoted by mesenchymal stem cells through VEGF.
    Zhang P; Dong L; Yan K; Long H; Yang TT; Dong MQ; Zhou Y; Fan QY; Ma BA
    Oncol Rep; 2013 Oct; 30(4):1753-61. PubMed ID: 23863999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TET2-dependent IL-6 induction mediated by the tumor microenvironment promotes tumor metastasis in osteosarcoma.
    Itoh H; Kadomatsu T; Tanoue H; Yugami M; Miyata K; Endo M; Morinaga J; Kobayashi E; Miyamoto T; Kurahashi R; Terada K; Mizuta H; Oike Y
    Oncogene; 2018 May; 37(22):2903-2920. PubMed ID: 29515232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anoikis resistant mediated by FASN promoted growth and metastasis of osteosarcoma.
    Sun T; Zhong X; Song H; Liu J; Li J; Leung F; Lu WW; Liu ZL
    Cell Death Dis; 2019 Apr; 10(4):298. PubMed ID: 30931932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between human osteosarcoma and mesenchymal stem cells via an interleukin-8 signaling loop in the tumor microenvironment.
    Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
    Cell Commun Signal; 2018 Apr; 16(1):13. PubMed ID: 29625612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells promote osteosarcoma cell survival and drug resistance through activation of STAT3.
    Tu B; Zhu J; Liu S; Wang L; Fan Q; Hao Y; Fan C; Tang TT
    Oncotarget; 2016 Jul; 7(30):48296-48308. PubMed ID: 27340780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of Osteosarcomas from a Combination of Rb Silencing and c-Myc Overexpression in Human Mesenchymal Stem Cells.
    Wang JY; Wu PK; Chen PC; Lee CW; Chen WM; Hung SC
    Stem Cells Transl Med; 2017 Feb; 6(2):512-526. PubMed ID: 28191765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SLC25A22 Promotes Proliferation and Metastasis of Osteosarcoma Cells via the PTEN Signaling Pathway.
    Chen MW; Wu XJ
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818811143. PubMed ID: 30482097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the Notch signaling pathway attenuates progression of cell motility, metastasis, and epithelial-to-mesenchymal transition-like phenomena induced by low concentrations of cisplatin in osteosarcoma.
    Dai G; Liu G; Zheng D; Song Q
    Eur J Pharmacol; 2021 May; 899():174058. PubMed ID: 33757752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human mesenchymal stem cells (hMSCs) target osteosarcoma and promote its growth and pulmonary metastasis.
    Xu WT; Bian ZY; Fan QM; Li G; Tang TT
    Cancer Lett; 2009 Aug; 281(1):32-41. PubMed ID: 19342158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells promote tumor engraftment and metastatic colonization in rat osteosarcoma model.
    Tsukamoto S; Honoki K; Fujii H; Tohma Y; Kido A; Mori T; Tsujiuchi T; Tanaka Y
    Int J Oncol; 2012 Jan; 40(1):163-9. PubMed ID: 21971610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effects of Interleukin-33 (IL-33) on Osteosarcoma Cell Viability, Apoptosis, and Epithelial-Mesenchymal Transition are Mediated Through the PI3K/AKT Pathway.
    Wang S; Zhao G; Zhao S; Qiao Y; Yang H
    Med Sci Monit; 2020 Apr; 26():e920766. PubMed ID: 32312946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microvesicles derived from human bone marrow mesenchymal stem cells promote U2OS cell growth under hypoxia: the role of PI3K/AKT and HIF-1α.
    Lin S; Zhu B; Huang G; Zeng Q; Wang C
    Hum Cell; 2019 Jan; 32(1):64-74. PubMed ID: 30506278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caprin-1, a novel Cyr61-interacting protein, promotes osteosarcoma tumor growth and lung metastasis in mice.
    Sabile AA; Arlt MJ; Muff R; Husmann K; Hess D; Bertz J; Langsam B; Aemisegger C; Ziegler U; Born W; Fuchs B
    Biochim Biophys Acta; 2013 Aug; 1832(8):1173-82. PubMed ID: 23528710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage-derived CCL18 promotes osteosarcoma proliferation and migration by upregulating the expression of UCA1.
    Su Y; Zhou Y; Sun YJ; Wang YL; Yin JY; Huang YJ; Zhang JJ; He AN; Han K; Zhang HZ; Yao Y; Lv XB; Hu HY
    J Mol Med (Berl); 2019 Jan; 97(1):49-61. PubMed ID: 30426155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPARCL1 suppresses osteosarcoma metastasis and recruits macrophages by activation of canonical WNT/β-catenin signaling through stabilization of the WNT-receptor complex.
    Zhao SJ; Jiang YQ; Xu NW; Li Q; Zhang Q; Wang SY; Li J; Wang YH; Zhang YL; Jiang SH; Wang YJ; Huang YJ; Zhang XX; Tian GA; Zhang CC; Lv YY; Dai M; Liu F; Zhang R; Zhou D; Zhang ZG
    Oncogene; 2018 Feb; 37(8):1049-1061. PubMed ID: 29084211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5.
    Ye F; Tian L; Zhou Q; Feng D
    Gene; 2019 Dec; 721():144093. PubMed ID: 31473323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anoikis-resistant subpopulations of human osteosarcoma display significant chemoresistance and are sensitive to targeted epigenetic therapies predicted by expression profiling.
    Foley JM; Scholten DJ; Monks NR; Cherba D; Monsma DJ; Davidson P; Dylewski D; Dykema K; Winn ME; Steensma MR
    J Transl Med; 2015 Apr; 13():110. PubMed ID: 25889105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.